These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22645112)

  • 21. Collagen VI is required for the structural and functional integrity of the neuromuscular junction.
    Cescon M; Gregorio I; Eiber N; Borgia D; Fusto A; Sabatelli P; Scorzeto M; Megighian A; Pegoraro E; Hashemolhosseini S; Bonaldo P
    Acta Neuropathol; 2018 Sep; 136(3):483-499. PubMed ID: 29752552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single Intramuscular Injection of AAV-shRNA Reduces DNM2 and Prevents Myotubular Myopathy in Mice.
    Tasfaout H; Lionello VM; Kretz C; Koebel P; Messaddeq N; Bitz D; Laporte J; Cowling BS
    Mol Ther; 2018 Apr; 26(4):1082-1092. PubMed ID: 29506908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of chronic prednisolone treatment on postjunctional membrane responses to agonist.
    Ribera AB; Nastuk WL
    Muscle Nerve; 1988 Mar; 11(3):265-9. PubMed ID: 2832755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice.
    Kong L; Wang X; Choe DW; Polley M; Burnett BG; Bosch-Marcé M; Griffin JW; Rich MM; Sumner CJ
    J Neurosci; 2009 Jan; 29(3):842-51. PubMed ID: 19158308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of in vivo injury on the neuromuscular junction in healthy and dystrophic muscles.
    Pratt SJP; Shah SB; Ward CW; Inacio MP; Stains JP; Lovering RM
    J Physiol; 2013 Jan; 591(2):559-70. PubMed ID: 23109110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of neostigmine and pyridostigmine at the neuromuscular junction.
    Gillies JD; Allen J
    Clin Exp Neurol; 1977; 14():271-9. PubMed ID: 616607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Slow-channel transgenic mice: a model of postsynaptic organellar degeneration at the neuromuscular junction.
    Gomez CM; Maselli R; Gundeck JE; Chao M; Day JW; Tamamizu S; Lasalde JA; McNamee M; Wollmann RL
    J Neurosci; 1997 Jun; 17(11):4170-9. PubMed ID: 9151734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A mouse model for congenital myasthenic syndrome due to MuSK mutations reveals defects in structure and function of neuromuscular junctions.
    Chevessier F; Girard E; Molgó J; Bartling S; Koenig J; Hantaï D; Witzemann V
    Hum Mol Genet; 2008 Nov; 17(22):3577-95. PubMed ID: 18718936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormalities in neuromuscular junction structure and skeletal muscle function in mice lacking the P2X2 nucleotide receptor.
    Ryten M; Koshi R; Knight GE; Turmaine M; Dunn P; Cockayne DA; Ford AP; Burnstock G
    Neuroscience; 2007 Sep; 148(3):700-11. PubMed ID: 17706883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subcellular localization of the glutamate transporters GLAST and GLT at the neuromuscular junction in rodents.
    Rinholm JE; Slettaløkken G; Marcaggi P; Skare Ø; Storm-Mathisen J; Bergersen LH
    Neuroscience; 2007 Mar; 145(2):579-91. PubMed ID: 17289278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GFPT1 deficiency in muscle leads to myasthenia and myopathy in mice.
    Issop Y; Hathazi D; Khan MM; Rudolf R; Weis J; Spendiff S; Slater CR; Roos A; Lochmüller H
    Hum Mol Genet; 2018 Sep; 27(18):3218-3232. PubMed ID: 29905857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correct expression and localization of collagen XIII are crucial for the normal formation and function of the neuromuscular system.
    Härönen H; Zainul Z; Naumenko N; Sormunen R; Miinalainen I; Shakirzyanova A; Santoleri S; Kemppainen AV; Giniatullin R; Pihlajaniemi T; Heikkinen A
    Eur J Neurosci; 2019 Jun; 49(11):1491-1511. PubMed ID: 30667565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuromuscular transmission defects in myopathies: Rare but worth searching for.
    Elahi B; Laughlin RS; Litchy WJ; Milone M; Liewluck T
    Muscle Nerve; 2019 Apr; 59(4):475-478. PubMed ID: 30536954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Affected female carriers of MTM1 mutations display a wide spectrum of clinical and pathological involvement: delineating diagnostic clues.
    Biancalana V; Scheidecker S; Miguet M; Laquerrière A; Romero NB; Stojkovic T; Abath Neto O; Mercier S; Voermans N; Tanner L; Rogers C; Ollagnon-Roman E; Roper H; Boutte C; Ben-Shachar S; Lornage X; Vasli N; Schaefer E; Laforet P; Pouget J; Moerman A; Pasquier L; Marcorelle P; Magot A; Küsters B; Streichenberger N; Tranchant C; Dondaine N; Schneider R; Gasnier C; Calmels N; Kremer V; Nguyen K; Perrier J; Kamsteeg EJ; Carlier P; Carlier RY; Thompson J; Boland A; Deleuze JF; Fardeau M; Zanoteli E; Eymard B; Laporte J
    Acta Neuropathol; 2017 Dec; 134(6):889-904. PubMed ID: 28685322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic efficacy of 3,4-Diaminopyridine phosphate on neuromuscular junction in Pompe disease.
    Bragato C; Blasevich F; Ingenito G; Mantegazza R; Maggi L
    Biomed Pharmacother; 2021 May; 137():111357. PubMed ID: 33724918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Participation of myosin Va and Pka type I in the regeneration of neuromuscular junctions.
    Röder IV; Strack S; Reischl M; Dahley O; Khan MM; Kassel O; Zaccolo M; Rudolf R
    PLoS One; 2012; 7(7):e40860. PubMed ID: 22815846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Muscle-restricted nuclear receptor interaction protein knockout causes motor neuron degeneration through down-regulation of myogenin at the neuromuscular junction.
    Chen HH; Tsai LK; Liao KY; Wu TC; Huang YH; Huang YC; Chang SW; Wang PY; Tsao YP; Chen SL
    J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):771-785. PubMed ID: 29608040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute severe animal model of anti-muscle-specific kinase myasthenia: combined postsynaptic and presynaptic changes.
    Richman DP; Nishi K; Morell SW; Chang JM; Ferns MJ; Wollmann RL; Maselli RA; Schnier J; Agius MA
    Arch Neurol; 2012 Apr; 69(4):453-60. PubMed ID: 22158720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Schwann Cells in Neuromuscular Junction Formation and Maintenance.
    Barik A; Li L; Sathyamurthy A; Xiong WC; Mei L
    J Neurosci; 2016 Sep; 36(38):9770-81. PubMed ID: 27656017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severely impaired neuromuscular synaptic transmission causes muscle weakness in the Cacna1a-mutant mouse rolling Nagoya.
    Kaja S; van de Ven RC; van Dijk JG; Verschuuren JJ; Arahata K; Frants RR; Ferrari MD; van den Maagdenberg AM; Plomp JJ
    Eur J Neurosci; 2007 Apr; 25(7):2009-20. PubMed ID: 17439489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.